Skip to main content
. 2022 Jan 29;13(3):505–510. doi: 10.1007/s13193-021-01491-6

Table 1.

Distribution of viable tumour, necrosis and teratoma across group 1 and group 2

Variables Group 1 (n = 42) Group 2 (n = 20)
Viable tumour 4 (1%) 3 (15%)
Viable tumour present despite size reduction of residual mass 1 2
Necrosis 25 (60%) 15 (75%)
Teratoma 14 (33%) 6 (30%)
Teratoma present despite size reduction of residual mass 7 4